Answers are grounded in this paper and cite their sources.
By comparing transcriptional changes in the context of clinical and virological measures, we identified differences in the host transcriptional response to pH1N1 virus across independent models of acute infection. Antiviral resistance and the emergence of new influenza viruses have placed more focus on developing drugs that target the immune system. Underlying overt clinical disease are molecular events that suggest therapeutic targets identified in one host may not be appropriate in another.
No takes yet. Share an insight, caveat, or question.
Go et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: